HPV vaccination coverage and barriers for people with disability: A scoping review

This scoping review explored human papillomavirus (HPV) vaccination coverage and barriers for people with disability. Our global search identified 33 studies, all from high-income countries, published between 2006 and 2025. We found evidence of inequalities in HPV vaccination coverage for people with disability across a range of countries, sexes/genders, settings, and disability groups. Common vaccination barriers included misassumptions around sexual activity, lack of vaccination recommendations from healthcare professionals in primarily healthcare-facility-based HPV vaccination programme settings, and lack of staff training/resources. There were marked gaps in population-wide research for all people with disability, research from low- and middle-income settings, and research including deaf or blind communities, or people with physical or psychosocial disability. Disability-inclusive research methodologies were limited and should be prioritized to ensure future research meets community needs. If HPV vaccination targets are to be achieved, equitable access must be supported for all people, including people with disability.

Authors

Institutions

Publication Details

Journal
Human Vaccines & Immunotherapeutics
Published
2026-10-16
DOI
https://doi.org/10.1080/21645515.2026.2738264
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HPV vaccination coverage and barriers for people with disability: A scoping review

Claire Melissa Vajdic, Glenda M. Bishop, Zoe Aitken, Sarah Walmsley et al.
Human Vaccines & Immunotherapeutics
Cervical Cancer and HPV Research
article

HPV vaccination coverage and barriers for people with disability: A scoping review

Claire Melissa Vajdic, Glenda M. Bishop, Zoe Aitken, Sarah Walmsley, Robert Long
article en

Abstract

This scoping review explored human papillomavirus (HPV) vaccination coverage and barriers for people with disability. Our global search identified 33 studies, all from high-income countries, published between 2006 and 2025. We found evidence of inequalities in HPV vaccination coverage for people with disability across a range of countries, sexes/genders, settings, and disability groups. Common vaccination barriers included misassumptions around sexual activity, lack of vaccination recommendations from healthcare professionals in primarily healthcare-facility-based HPV vaccination programme settings, and lack of staff training/resources. There were marked gaps in population-wide research for all people with disability, research from low- and middle-income settings, and research including deaf or blind communities, or people with physical or psychosocial disability. Disability-inclusive research methodologies were limited and should be prioritized to ensure future research meets community needs. If HPV vaccination targets are to be achieved, equitable access must be supported for all people, including people with disability.

Human Vaccines & ImmunotherapeuticsVol. 22(1)
Australian Bureau of Statistics (AU), The University of Melbourne (AU), UNSW Sydney (AU), Kirby Institute (AU)
Australian Research Council, National Health and Medical Research Council, Medical Research Future Fund
Reduced inequalities, Good health and well-being
Openalex Percentile: Top 12%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.